[Contribution to the study of erythromycin combined with betaine, in controlling the most common toxi-infectious states in medical practice].
D001622:Betaine / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D010031:Otitis / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D001622:Betaine; D004917:Erythromycin
Contribuição ao estudo da eritromicina, associada à betaína, no combate aos estados toxiinfecciosos mais comuns da prática médica.